Sally Nijim is the Biomedical Leadership Fellow for Dr. Fajgenbaum’s team at the CDCN. She also serves in this role at the Center for Cytokine Storm Treatment & Laboratory (CSTL). She is heavily involved in spearheading projects and has been previously involved in several projects at the intersection of innovation, entrepreneurship, and medicine with the Center for Healthcare Innovation at the University of Pennsylvania. She is a third year 21st Century Scholar and medical student at the University of Pennsylvania Perelman School of Medicine. She earned her AB degree in Chemical and Physical Biology from Harvard University with a secondary in Global Health and Health Policy.